2008 Drug Discovery for Neurodegeneration Conference

Washington, DC - February 4-5, 2008

Park Hyatt Washington DC

Presented by the Alzheimer's Drug Discovery Foundation

General Information   Speakers   Program    Accommodations   Registration   Sponsorship   Supporters

CHAIRS, SPEAKERS and FACILITATORS

Duncan Beniston, PhD, ChemBridge Corporation (confirmed)

Neil Buckholtz, PhD, National Institute on Aging (confirmed)

Robert Elfont, MD, PhD (confirmed)

Howard Fillit, MD, Executive Director, ADDF (confirmed)

Marcie Glicksman, PhD, Harvard Medical School (confirmed)

Pierre Goloubinoff, PhD, University of Lausanne (confirmed)

Barry Greenberg, PhD, Neurochem, Inc. (confirmed)

Kate Haviland, PTC Therapeutics, Inc. (confirmed)

Jill Heemskerk, PhD, National Institute of Neurological Disorders and Stroke (confirmed)

Franz Hefti, PhD, Avid Radiopharmaceuticals (confirmed)

Kim Hunter-Schaedle, PhD, Children’s Tumor Foundation (confirmed)

Christopher A. Lipinski, PhD, Melior Discovery (confirmed)

Frank Longo, MD, PhD, Stanford University (confirmed)

David Lowe, PhD, Memory Pharmaceuticals (confirmed)

Kalpana Merchant, PhD, Eli Lilly and Company (confirmed)

Elias Michaelis, MD, PhD, University of Kansas (confirmed)

Christopher Moxham, PhD, Merck Research Laboratories (confirmed)

Jeffrey S. Nye, MD, PhD, Johnson and Johnson Pharma R&D, LLC  (confirmed)

Suzana Petanceska, PhD, National Institute on Aging (confirmed)                    

Robert Powell, Food and Drug Administration (FDA) (confirmed)

Lorenzo Refolo, PhD, National Institute of Neurological Disorders and Stroke (confirmed)

Peter Reinhart, PhD, Wyeth Research  (confirmed)

Kenneth J. Rhodes, PhD, Biogen Idec, Inc.  (confirmed)

Jeffrey Rothstein, MD, PhD, Johns Hopkins University (confirmed)

Barbara Sahagan, PhD, Pfizer, Inc. (confirmed)

Peter Seubert, PhD, Elan Pharmaceuticals (confirmed)

Todd Sherer, PhD, Michael J. Fox Foundation (confirmed)

Richard Silverman, PhD, Northwestern University (confirmed)

Edward Spack, PhD, SRI International (confirmed)

Douglas K. Spracklin, PhD, Pfizer Global Research and Development (confirmed)

Ross Stein, PhD, Harvard Medical School & Brigham and Women’s Hospital (confirmed)

Jordan Tang, PhD, Oklahoma Medical Research Foundation (confirmed)

Linda Van Eldik, PhD, Northwestern University (confirmed)

D. Martin Watterson, PhD, Northwestern University (confirmed)

 

top